The FDA Wants to Talk Psychedelic Therapy. The Movement Has Bigger Questions.
A federal docket on the therapeutic use of psychedelics is open through October 5. Four groups that built this movement from the ground up on what they’d tell the government, what they’re fighting in court, and how much of their work the docket doesn’t cover. The Food and Drug Administration held a public hearing on… Keep Reading